NOTICE OF ALLOWANCE - ISSUED
issued
on 27 Aug 2024
Last Applicant/ Owned by
66 Hudson Boulevard East
New York
NY
100012192
Serial Number
98202588 filed on 28th Sep 2023
Registration Number
N/A
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
YORLANI
Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disor Read More
Classification Information
Class [005]
Pharmaceutical Products
Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 98202588
Mark Type
No Service/Collective Mark
Attorney Docket Number
No
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 27th Aug 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 02th Jul 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 02th Jul 2024 | PUBLISHED FOR OPPOSITION |
| 12th Jun 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 28th May 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 21st May 2024 | ASSIGNED TO EXAMINER |
| 12th Oct 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| 02th Oct 2023 | NEW APPLICATION ENTERED |